Company Filing History:
Years Active: 2008
Title: Innovations in Diabetes Therapy by Andreas H R Pfuetzner
Introduction
Andreas H R Pfuetzner is a notable inventor based in Munich, Germany. He has made significant contributions to the field of diabetes therapy through his innovative research and development. His work focuses on creating effective pharmaceutical compositions that can improve the management of diabetes.
Latest Patents
Pfuetzner holds a patent for a groundbreaking invention titled "Multiple agent diabetes therapy." This patent includes a pharmaceutical composition that comprises at least two agents selected from specific groups. Agent i) is chosen from insulin, insulin analogs, or their physiologically active fragments. Agent ii) includes insulin-related peptides and their analogs, along with their active fragments. Finally, agent iii) is an insulin sensitizer. This innovative approach aims to enhance the effectiveness of diabetes treatment.
Career Highlights
Pfuetzner is currently associated with Minimed, Inc., where he continues to work on advancing diabetes therapies. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry. His contributions have the potential to significantly impact the lives of individuals living with diabetes.
Collaborations
One of his notable collaborators is William P Van Antwerp. Together, they have worked on various projects aimed at improving diabetes management through innovative therapies.
Conclusion
Andreas H R Pfuetzner's work in diabetes therapy exemplifies the importance of innovation in healthcare. His patent for multiple agent diabetes therapy represents a significant advancement in the field, showcasing his commitment to improving patient outcomes.